Ellen Relkin Esq.

Weitz & Luxenberg P.C.
Relkin, Ellen

Ellen Relkin, Of Counsel with Weitz & Luxenberg P.C. in New York, focuses her practice on pharmaceutical and medical device product liability and toxic tort matters. Ms. Relkin has represented plaintiffs injured by the birth control patch Ortho Evra, the acne drug Accutane, the oral contraceptives Yaz, Yasmin and Ocella, Hydroxycut dietary supplement products, defective Zimmer Durom Cup hip implants, and those who suffered serious health problems related to their mother’s use of the drug DES during pregnancy, among other defective medical products.

In April 2006, she was part of the trial team that secured a $13.5 million verdict against Merck in a failure-to-warn case involving Vioxx and the risk for heart attack and she successfully defended the compensatory damage verdict on appeal.

Ms. Relkin, who is certified by the New Jersey Supreme Court as a Civil Trial Attorney, has spoken on scientific evidence issues and has published articles on the subject in the Cardozo Law Review and the Dickinson Journal of Environmental Law And Policy. In addition, Ms. Relkin serves on the board of advisors for The Toxics Law Reporter and the MDEX Daubert Reporter.

Her litigation areas include: Stryker Rejuvenate and AGB II hips, Biomet Magnum M2a hips, Wright Conserve hips, DePuy Hips, Zimmer NexGen Hi-Flex Knees, Accutane, and Endicott, NY IBM Vapor Intrusion.

Ms. Relkin received her B.A., cum laude, from Cornell University and her J.D. from Rutgers University Law School.



У нашей компании интересный блог , он рассказывает про Левитра 10 мг https://cialis-viagra.com.ua